Lauritz was born in Lüneburg (1993). He is currently in his final year of medical school at the Christian-Albrechts-University Kiel in Germany (CAU, 2013-2021). During his studies he developed a strong interest for oncology and conducted numerous clinical electives at oncology departments in Kiel, Hamburg and Edinburgh. Recognizing that a deep understanding of the biology is needed to extend insights into clinical problems, he decided to take a year off medical school in 2016 to undertake an experimental project for his MD thesis. Under the supervision of Prof. Susanne Sebens, Lauritz studied the interaction of pancreatic cancer cells with the metastatic liver microenvironment, trying to elucidate how the inflammatory status of the liver affects the outgrowth of liver metastasis. For this work, he was awarded an MD scholarship by the medical faculty of the CAU, as well as travel grant to present his findings at a national congress on pancreatic cancer. After this research year, he continued his research work in the Sebens Lab part-time while continuing medical school. To further broaden his scientific horizon and gain a more profound knowledge of cancer metastasis, he recently obtained the prestigious Boehringer-Ingelheim Fonds MD fellowship to join the Brain Metastasis Group. His goal is to study the molecular biology of radio-resistance in brain metastasis, in order to find novel therapeutic targets and biomarkers that improve the management of patients with brain metastasis.